Subfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD)
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (NCT00284089) | Novartis | 2005-04-01 |
Track Subfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD) automatically
Every clearance here is in the API, with alerts when new ones post.